Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities

• Published in: Frontiers in genetics Vol. 15; p. 1416772
• Main Authors: Hazra, Rasmani, Debnath, Rinku, Tuppad, Arati
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 02-07-2024
• Subjects: cancer stem cells; Genetics; glioblastoma; glioblastoma stem cells; lncRNAs; long non-coding RNAs; therapeutic targets; lncRNAs; glioblastoma; glioblastoma stem cells; 3D in vitro model; cancer stem cells; therapeutic targets; long non-coding RNAs
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2024.1416772

Glioblastoma poses a formidable challenge among primary brain tumors: its tumorigenic stem cells, capable of self-renewal, proliferation, and differentiation, contribute substantially to tumor initiation and therapy resistance. These glioblastoma stem cells (GSCs), resembling conventional stem and progenitor cells, adopt pathways critical for tissue development and repair, promoting uninterrupted tumor expansion. Long non-coding RNAs (lncRNAs), a substantial component of the human transcriptome, have garnered considerable interest for their pivotal roles in normal physiological processes and cancer pathogenesis. They display cell- or tissue-specific expression patterns, and extensive investigations have highlighted their impact on regulating GSC properties and cellular differentiation, thus offering promising avenues for therapeutic interventions. Consequently, lncRNAs, with their ability to exert regulatory control over tumor initiation and progression, have emerged as promising targets for innovative glioblastoma therapies. This review explores notable examples of GSC-associated lncRNAs and elucidates their functional roles in driving glioblastoma progression. Additionally, we delved deeper into utilizing a 3D
model for investigating GSC biology and elucidated four primary methodologies for targeting lncRNAs as potential therapeutics in managing glioblastoma.